PETALUMA, Calif.--(BUSINESS WIRE)--Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn® Technology platform, today announced that the financial results for its fiscal third quarter ended December 31, 2008, will be released after the U.S. market closes on February 12, 2009. The earnings release will be followed by a conference call at 1:30 p.m. PT (4:30 p.m. ET) on February 12, 2009, to discuss fiscal third quarter results and provide a corporate update to the investment community.
